Igor Bilinsky
Chief Operating Officer at Iovance Biotherapeutics, Inc. (IOVA) since March 2021
Igor Bilinsky has filed 32 insider reports with the SEC since February 2021, as chief Operating Officer at Iovance Biotherapeutics, Inc. (IOVA) and officer at Oncternal Therapeutics, Inc. (ONCT). The latest filing, on September 10, 2026, reports shares withheld for taxes or exercise price and exercise or conversion of a derivative at Iovance Biotherapeutics, Inc. (IOVA).
- Filings
- 32
- Companies
- 2
- Bought on market
- None
- Sold on market
- None
Companies where Igor Bilinsky is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Chief Operating Officersince March 2021 | 142,074 | $7.31 | Sep 10, 2026 | ||||
| Officer | Feb 16, 2021 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Sep 8, 2026IOVAChief Operating Officer Bilinsky Igor covered exercise/tax liability with 3,976 shares and converted options into 7,813 shares, increasing direct ownership by 3% to 142,074 units to satisfy withholding taxForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Sep 1, 2026IOVAChief Operating Officer Bilinsky Igor converted options into 8,789 shares and covered exercise/tax liability with 4,472 shares, increasing direct ownership by 3% to 138,237 units (withholding tax)Form 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Jun 5, 2026IOVAChief Operating Officer Bilinsky Igor converted options into 7,813 shares and covered exercise/tax liability with 3,976 shares, increasing direct ownership by 3% to 133,920 units (for withholding tax)Form 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Jun 1, 2026IOVAChief Operating Officer Bilinsky Igor converted options into 8,790 shares and covered exercise/tax liability with 4,473 shares, increasing direct ownership by 3% to 130,083 units (tax withholding)Form 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Mar 5, 2026IOVAChief Operating Officer Bilinsky Igor converted options into 31,246 shares and covered exercise/tax liability with 16,628 shares, increasing direct ownership by 13% to 125,766 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Mar 2, 2026IOVAChief Operating Officer Bilinsky Igor converted options into 12,307 shares and covered exercise/tax liability with 6,903 shares, increasing direct ownership by 5% to 111,148 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Dec 2, 2025IOVAChief Operating Officer Bilinsky Igor covered exercise/tax liability with 6,250 shares and converted options into 12,305 shares, increasing direct ownership by 6% to 105,744 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Sep 2, 2025IOVAChief Operating Officer Bilinsky Igor converted options into 12,306 shares and covered exercise/tax liability with 6,250 shares, increasing direct ownership by 6% to 99,689 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Jun 2, 2025IOVAChief Operating Officer Bilinsky Igor converted options into 12,305 shares and covered exercise/tax liability with 6,250 shares, increasing direct ownership by 7% to 93,633 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Mar 5, 2025IOVASEC Form 4 filed by Chief Operating Officer Bilinsky IgorForm 4Grant or award
- Mar 3, 2025IOVAChief Operating Officer Bilinsky Igor covered exercise/tax liability with 33,302 shares and converted options into 62,106 shares, increasing direct ownership by 49% to 87,578 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Jan 14, 2025IOVAChief Operating Officer Bilinsky Igor converted options into 2,813 shares and covered exercise/tax liability with 1,578 shares, increasing direct ownership by 2% to 58,774 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Dec 2, 2024IOVAChief Operating Officer Bilinsky Igor converted options into 3,516 shares and covered exercise/tax liability with 1,784 shares, increasing direct ownership by 3% to 57,539 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Oct 14, 2024IOVAChief Operating Officer Bilinsky Igor converted options into 2,813 shares and covered exercise/tax liability with 1,428 shares, increasing direct ownership by 3% to 55,807 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Sep 3, 2024IOVAChief Operating Officer Bilinsky Igor converted options into 26,954 shares and covered exercise/tax liability with 13,675 shares, increasing direct ownership by 32% to 54,422 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Jul 15, 2024IOVAChief Operating Officer Bilinsky Igor covered exercise/tax liability with 1,428 shares and converted options into 2,813 shares, increasing direct ownership by 3% to 41,143 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Jun 3, 2024IOVABilinsky Igor converted options into 3,516 shares and covered exercise/tax liability with 1,784 shares, increasing direct ownership by 5% to 39,758 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Apr 15, 2024IOVABilinsky Igor converted options into 2,812 shares and covered exercise/tax liability with 1,427 shares, increasing direct ownership by 4% to 38,026 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Mar 4, 2024IOVABilinsky Igor converted options into 14,061 shares and covered exercise/tax liability with 7,287 shares, increasing direct ownership by 23% to 36,641 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Mar 1, 2024IOVASEC Form 4 filed by Bilinsky IgorForm 4Grant or award
- Jan 16, 2024IOVABilinsky Igor converted options into 2,813 shares and covered exercise/tax liability with 1,577 shares, increasing direct ownership by 4% to 29,867 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Oct 16, 2023IOVABilinsky Igor converted options into 2,813 shares and covered exercise/tax liability with 1,395 shares, increasing direct ownership by 5% to 28,631 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Jul 14, 2023IOVASEC Form 4 filed by Bilinsky IgorForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Apr 14, 2023IOVASEC Form 4 filed by Bilinsky IgorForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Jan 17, 2023IOVASEC Form 4: Bilinsky Igor converted options into 11,248 shares and covered exercise/tax liability with 4,671 shares, increasing direct ownership by 37% to 24,378 units (tax withholding)Form 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Jan 3, 2023IOVASEC Form 4: Bilinsky Igor converted options into 18,850 shares and covered exercise/tax liability with 10,553 shares, increasing direct ownership by 87% to 17,801 units (tax withholding)Form 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Jun 14, 2022IOVASEC Form 4: Bilinsky Igor converted options into 18,850 shares and covered exercise/tax liability with 9,346 shares (for tax liability)Form 4Grant or awardShares withheld for taxes or exercise priceExercise or conversion of a derivative
- Jan 14, 2022IOVASEC Form 4 filed by Bilinsky IgorForm 4Grant or award
- Jun 14, 2021IOVASEC Form 4 filed by BILINSKY IGORForm 4Grant or award
- Mar 15, 2021IOVASEC Form 3 filed by Igor BilinskyForm 3New insider
- Mar 15, 2021IOVASEC Form 4 filed by Igor BilinskyForm 4Grant or award
- Feb 11, 2021ONCTSEC Form 4 filed by Igor BilinskyForm 4Grant or award
Compare Igor Bilinsky with
- Igor Bilinsky vs Frederick G Vogt1 shared
- Igor Bilinsky vs Daniel Gordon Kirby1 shared
- Igor Bilinsky vs Corleen M. Roche1 shared
- Igor Bilinsky vs Noah Berkowitz1 shared
- Igor Bilinsky vs Raj K. Puri1 shared
- Igor Bilinsky vs Michael Weiser1 shared
Other insiders at the same companies
- Frederick G VogtIOVA
- Daniel Gordon KirbyIOVA
- Corleen M. RocheIOVA
- Noah BerkowitzIOVA
- Raj K. PuriIOVA
- Michael WeiserIOVA
- Iain D. DukesIOVA
- Athena CountouriotisIOVA
- Ryan D MaynardIOVA
- Finckenstein Friedrich GrafIOVA
- Matthew W. RosinackIOVA
- Wendy L YarnoIOVA
- Jean-Marc BelleminIOVA
Questions about Igor Bilinsky
- What is Igor Bilinsky's role at Iovance Biotherapeutics, Inc.?
- Igor Bilinsky reports to the SEC as chief Operating Officer at Iovance Biotherapeutics, Inc. (IOVA), according to the latest filing on September 10, 2026. Igor Bilinsky has also filed as officer at Oncternal Therapeutics, Inc. (ONCT).
- How many shares does Igor Bilinsky own?
- After the latest filing that states it, Igor Bilinsky directly owned 142,074 shares of Iovance Biotherapeutics, Inc. (IOVA). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Igor Bilinsky bought or sold stock recently?
- No open-market purchases or sales by Igor Bilinsky are on file. The filings report shares withheld for taxes or exercise price, exercise or conversion of a derivative and grant or award.
- How do I get alerts when Igor Bilinsky files?
- Follow Igor Bilinsky on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Igor Bilinsky filed 2 times in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Igor Bilinsky (SEC CIK 0001594604). Totals count each trade once, skipping amendments whose original is on file, from Feb 16, 2021 on. View on SEC EDGAR · Get this as JSON